Sandoz Inc. Recalls One Lot of Losartan Potassium and Hydrochlorothiazide Tablets Due to NDEA Impurities in API

According to the U.S. Food and Drug Administration (FDA), Sandoz Inc. issued a voluntary nationwide recall on one lot of Losartan Potassium Hydrochlorothiazide tablets, USP 100mg/25mg on Friday, November 9….

Read All Global Disruptions

Recent Global Disruptions